Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 3 (3), 679-92

Fetal Aneuploidy Detection by Cell-Free DNA Sequencing for Multiple Pregnancies and Quality Issues With Vanishing Twins


Fetal Aneuploidy Detection by Cell-Free DNA Sequencing for Multiple Pregnancies and Quality Issues With Vanishing Twins

Sebastian Grömminger et al. J Clin Med.


Non-invasive prenatal testing (NIPT) by random massively parallel sequencing of maternal plasma DNA for multiple pregnancies is a promising new option for prenatal care since conventional non-invasive screening for fetal trisomies 21, 18 and 13 has limitations and invasive diagnostic methods bear a higher risk for procedure related fetal losses in the case of multiple gestations compared to singletons. In this study, in a retrospective blinded analysis of stored twin samples, all 16 samples have been determined correctly, with four trisomy 21 positive and 12 trisomy negative samples. In the prospective part of the study, 40 blood samples from women with multiple pregnancies have been analyzed (two triplets and 38 twins), with two correctly identified trisomy 21 cases, confirmed by karyotyping. The remaining 38 samples, including the two triplet pregnancies, had trisomy negative results. However, NIPT is also prone to quality issues in case of multiple gestations: the minimum total amount of cell-free fetal DNA must be higher to reach a comparable sensitivity and vanishing twins may cause results that do not represent the genetics of the living sibling, as described in two case reports.

Keywords: NIPT; aneuploidy; cell-fee fetal DNA; multiple pregnancies; random massively parallel sequencing; trisomy; vanishing twin.


Figure 1
Figure 1
Correlation of the amount of male specific DNA to the fetal fraction measured by QuantYfeX for study cases with known fetal genders.

Similar articles

See all similar articles

Cited by 4 PubMed Central articles


    1. Benn P., Borell A., Chiu R., Cuckle H., Dugoff L., Faas B., Gross S., Johnson J., Maymon R., Norton M., et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prena. Diagn. 2013;33:622–629. doi: 10.1002/pd.4139. - DOI - PubMed
    1. Nikolaides K.H. The 11–13 + 6 weeks scan. [(accessed on 20 March 2014)]. Available online:
    1. Agarwal K., Alfirevic Z. Pregnancy loss after chorionic villus sampling and genetic amniocentesis in twin pregnancies: A systematic review. Ultrasound Obstet. Gynecol. 2012;40:128–134. doi: 10.1002/uog.10152. - DOI - PubMed
    1. Chiu R.W., Akolekar R., Zheng Y.W., Leung T.Y., Sun H., Chan K.C., Lun F.M., Go A.T., Lau E.T., To W.W., et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large-scale validity study. BMJ. 2011;342 doi: 10.1136/bmj.c7401. - DOI - PMC - PubMed
    1. Ehrich M., Deciu C., Zwiefelhofer T., Tynan J.A., Cagasan L., Tim R., Lu V., McCullough R., Mc-Carthy E., Nygren A.O., et al. Noninvasive detection of fetal tri-somy 21 by sequencing of DNA in maternal blood: A study in a clinical setting. Am. J. Obstet. Gynecol. 2011;204 doi: 10.1016/j.ajog.2010.12.060. - DOI - PubMed